BACTI_B: Aims for SEK 600m revenue and SEK 200m EBITDA by 2030 through license-driven growth

About this update from Bactiguard Holding Ab

Bactiguard targets at least SEK 600 million in revenue and SEK 200 million EBITDA by 2030, focusing on license partnerships in high-need therapeutic areas and leveraging operational scale for growth. Partnerships with major MedTech firms and a strong wound management portfolio support these goals.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Bactiguard Holding Ab